NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1907068278|ref|XP_036019513|]
View 

tensin-1 isoform X28 [Mus musculus]

Protein Classification

SH2_Tensin_like and PTB_tensin domain-containing protein( domain architecture ID 10177789)

SH2_Tensin_like and PTB_tensin domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

 Name Accession Description Interval E-value
PTB_tensin cd01213
Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which ...
 1142-1275 7.13e-87

Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which contains a C-terminal SH2 domain followed by a PTB domain. PTB domains have a common PH-like fold and are found in various eukaryotic signaling molecules. This domain was initially shown to binds peptides with a NPXY motif with differing requirements for phosphorylation of the tyrosine, although more recent studies have found that some types of PTB domains can bind to peptides lack tyrosine residues altogether. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. PTB domains are classified into three groups: phosphotyrosine-dependent Shc-like, phosphotyrosine-dependent IRS-like, and phosphotyrosine-independent Dab-like PTB domains. This cd is part of the Dab-like subgroup.


:

Pssm-ID: 269924  Cd Length: 136  Bit Score: 277.59  E-value: 7.13e-87
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1142 GAACNVLFVNSVDMESLTGPQAISKATSETLAADPTPAATIVHFKVSAQGITLTDNQRKLFFRRHYPLNTVTFCDLDPQE 1221
Cdd:cd01213      1 GAACNVLYLGSVDTESLTGPQAVRKAVSETLERDPLPTPTVVHFKVSEQGITLTDNQRKLFFRRHYPLNTVSFCGMDPEN 80

                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1907068278 1222 RKWMKTE--GGAPAKLFGFVARKQGSTTDNACHLFAELDPNQPASAIVNFVSKVML 1275
Cdd:cd01213     81 RKWQKYDlrGSKPSRIFGFVARKQGSSTENVCHLFAELDPEQPASAIVNFVNKVLL 136
SH2_Tensin_like cd09927
Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. ...
 1005-1120 9.46e-67

Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. The Tensins are a family of intracellular proteins that interact with receptor tyrosine kinases (RTKs), integrins, and actin. They are thought act as signaling bridges between the extracellular space and the cytoskeleton. There are four homologues: Tensin1, Tensin2 (TENC1, C1-TEN), Tensin3 and Tensin4 (cten), all of which contain a C-terminal tandem SH2-PTB domain pairing, as well as actin-binding regions that may localize them to focal adhesions. The isoforms of Tensin2 and Tensin3 contain N-terminal C1 domains, which are atypical and not expected to bind to phorbol esters. Tensins 1-3 contain a phosphatase (PTPase) and C2 domain pairing which resembles PTEN (phosphatase and tensin homologue deleted on chromosome 10) protein. PTEN is a lipid phosphatase that dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to yield phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). As PtdIns(3,4,5)P3 is the product of phosphatidylinositol 3-kinase (PI3K) activity, PTEN is therefore a key negative regulator of the PI3K pathway. Because of their PTEN-like domains, the Tensins may also possess phosphoinositide-binding or phosphatase capabilities. However, only Tensin2 and Tensin3 have the potential to be phosphatases since only their PTPase domains contain a cysteine residue that is essential for catalytic activity. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


:

Pssm-ID: 198181 [Multi-domain]  Cd Length: 116  Bit Score: 220.38  E-value: 9.46e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1005 TSKYWYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVSSPPPTITQQGKKGDMTHELVRHFLIETGPRGVKL 1084
Cdd:cd09927      1 TSKYWYKPNISRDQAIALLKDKPPGTFLVRDSTTYKGAYGLAVKVATPPPGVNPFEAKGDPESELVRHFLIEPSPKGVKL 80

                           90       100       110
                   ....*....|....*....|....*....|....*.
gi 1907068278 1085 KGCPNEPNFGSLSALVYQHSVIPLALPCKLVIPSRD 1120
Cdd:cd09927     81 KGCPNEPVFGSLSALVYQHSITPLALPCKLRIPDRD 116
PHA03247 super family cl33720
large tegument protein UL36; Provisional
 333-851 4.13e-09

large tegument protein UL36; Provisional


The actual alignment was detected with superfamily member PHA03247:

Pssm-ID: 223021 [Multi-domain]  Cd Length: 3151  Bit Score: 61.49  E-value: 4.13e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  333 PAGSNQSFHPKSPASSTFLPSPHSSAGP---QEPPASLPGLIAQPQLPPKETTSDPSRTPEEEPlnleglvahrvAVYNA 409
Cdd:PHA03247  2580 PAVTSRARRPDAPPQSARPRAPVDDRGDprgPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPP-----------PTVPP 2648

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  410 RLQSLRQSRGFQPSPHWRRSAslsgvQARERQPAEPPGPLRRRAAsdgqyenqsPEATSPRSPGVRSPVQCVSPELALTI 489
Cdd:PHA03247  2649 PERPRDDPAPGRVSRPRRARR-----LGRAAQASSPPQRPRRRAA---------RPTVGSLTSLADPPPPPPTPEPAPHA 2714

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  490 ALNPGGRPKEPhlhsykeafEEMEGTSPSSPPHSVARSPPGLAKTPLSAlgLKPHNPADILLHPTGEEDEGEEVTKPPEE 569
Cdd:PHA03247  2715 LVSATPLPPGP---------AAARQASPALPAAPAPPAVPAGPATPGGP--ARPARPPTTAGPPAPAPPAAPAAGPPRRL 2783

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  570 PRSYVESVARTAVAGPRAQDVEPKSFSAPAAHAyghetplrngtpggsfvspsplstssPILSADSTSVGSFPSVVSSDQ 649
Cdd:PHA03247  2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAA--------------------------ALPPAASPAGPLPPPTSAQPT 2837

                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  650 GPRTPFQPMLDSSIRSGSLGQPSPAALSYQSSSPVPVGGSSYNSPDYSLQ--PFSSSPESQGQPQYSAASvhmvPGSPQA 727
Cdd:PHA03247  2838 APPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLArpAVSRSTESFALPPDQPER----PPQPQA 2913

                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  728 RHRTVGTNTPPSPGFGRRAVnPTMAAPGSPSLSHRQVMGPSGPgfhgnvvsgHPASAATTPGSPSLGRHPVGSHQVPGLH 807
Cdd:PHA03247  2914 PPPPQPQPQPPPPPQPQPPP-PPPPRPQPPLAPTTDPAGAGEP---------SGAVPQPWLGALVPGRVAVPRFRVPQPA 2983

                          490       500       510       520
                   ....*....|....*....|....*....|....*....|....*
gi 1907068278  808 SSVVT-TPGSPSLGRHPGAHQGNLASSLHSNAVISPGSPSLGRHL 851
Cdd:PHA03247  2984 PSREApASSTPPLTGHSLSRVSSWASSLALHEETDPPPVSLKQTL 3028
 
Name Accession Description Interval E-value
PTB_tensin cd01213
Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which ...
 1142-1275 7.13e-87

Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which contains a C-terminal SH2 domain followed by a PTB domain. PTB domains have a common PH-like fold and are found in various eukaryotic signaling molecules. This domain was initially shown to binds peptides with a NPXY motif with differing requirements for phosphorylation of the tyrosine, although more recent studies have found that some types of PTB domains can bind to peptides lack tyrosine residues altogether. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. PTB domains are classified into three groups: phosphotyrosine-dependent Shc-like, phosphotyrosine-dependent IRS-like, and phosphotyrosine-independent Dab-like PTB domains. This cd is part of the Dab-like subgroup.


Pssm-ID: 269924  Cd Length: 136  Bit Score: 277.59  E-value: 7.13e-87
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1142 GAACNVLFVNSVDMESLTGPQAISKATSETLAADPTPAATIVHFKVSAQGITLTDNQRKLFFRRHYPLNTVTFCDLDPQE 1221
Cdd:cd01213      1 GAACNVLYLGSVDTESLTGPQAVRKAVSETLERDPLPTPTVVHFKVSEQGITLTDNQRKLFFRRHYPLNTVSFCGMDPEN 80

                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1907068278 1222 RKWMKTE--GGAPAKLFGFVARKQGSTTDNACHLFAELDPNQPASAIVNFVSKVML 1275
Cdd:cd01213     81 RKWQKYDlrGSKPSRIFGFVARKQGSSTENVCHLFAELDPEQPASAIVNFVNKVLL 136
SH2_Tensin_like cd09927
Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. ...
 1005-1120 9.46e-67

Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. The Tensins are a family of intracellular proteins that interact with receptor tyrosine kinases (RTKs), integrins, and actin. They are thought act as signaling bridges between the extracellular space and the cytoskeleton. There are four homologues: Tensin1, Tensin2 (TENC1, C1-TEN), Tensin3 and Tensin4 (cten), all of which contain a C-terminal tandem SH2-PTB domain pairing, as well as actin-binding regions that may localize them to focal adhesions. The isoforms of Tensin2 and Tensin3 contain N-terminal C1 domains, which are atypical and not expected to bind to phorbol esters. Tensins 1-3 contain a phosphatase (PTPase) and C2 domain pairing which resembles PTEN (phosphatase and tensin homologue deleted on chromosome 10) protein. PTEN is a lipid phosphatase that dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to yield phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). As PtdIns(3,4,5)P3 is the product of phosphatidylinositol 3-kinase (PI3K) activity, PTEN is therefore a key negative regulator of the PI3K pathway. Because of their PTEN-like domains, the Tensins may also possess phosphoinositide-binding or phosphatase capabilities. However, only Tensin2 and Tensin3 have the potential to be phosphatases since only their PTPase domains contain a cysteine residue that is essential for catalytic activity. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198181 [Multi-domain]  Cd Length: 116  Bit Score: 220.38  E-value: 9.46e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1005 TSKYWYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVSSPPPTITQQGKKGDMTHELVRHFLIETGPRGVKL 1084
Cdd:cd09927      1 TSKYWYKPNISRDQAIALLKDKPPGTFLVRDSTTYKGAYGLAVKVATPPPGVNPFEAKGDPESELVRHFLIEPSPKGVKL 80

                           90       100       110
                   ....*....|....*....|....*....|....*.
gi 1907068278 1085 KGCPNEPNFGSLSALVYQHSVIPLALPCKLVIPSRD 1120
Cdd:cd09927     81 KGCPNEPVFGSLSALVYQHSITPLALPCKLRIPDRD 116
PTB pfam08416
Phosphotyrosine-binding domain; The phosphotyrosine-binding domain (PTB, also ...
 1144-1280 1.40e-37

Phosphotyrosine-binding domain; The phosphotyrosine-binding domain (PTB, also phosphotyrosine-interaction or PI domain) in the protein tensin tends to be found at the C-terminus. Tensin is a multi-domain protein that binds to actin filaments and functions as a focal-adhesion molecule (focal adhesions are regions of plasma membrane through which cells attach to the extracellular matrix). Human tensin has actin-binding sites, an SH2 (pfam00017) domain and a region similar to the tumour suppressor PTEN. The PTB domain interacts with the cytoplasmic tails of beta integrin by binding to an NPXY motif.


Pssm-ID: 429984  Cd Length: 131  Bit Score: 137.48  E-value: 1.40e-37
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1144 ACNVLFVNSVDMESLTGPQAISKAT--SETLAADPTPAATIVHFKVSAQGITLTDNQRKLFFrRHYPLNTVTFCDLDPQE 1221
Cdd:pfam08416    1 QYRVEHLTTFELDSLTGLQAVEDAIrkLQLLDAQGRVWTQEMLLQVSDQGITLTDNETKEEL-ESYPLDSISHCQAVLND 79

                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1907068278 1222 RKWmkteggapAKLFGFVARKQGSTTDNAcHLFA--ELDPNQPASAIVNFVSKVMLSAGQK 1280
Cdd:pfam08416   80 GRY--------NSILALVCQEPGQSKPDV-HLFQcdELGAELIAEDIESALSDVRLGKPKK 131
PTB smart00462
Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain; PTB/PI domain ...
 1141-1281 2.43e-22

Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain; PTB/PI domain structure similar to those of pleckstrin homology (PH) and IRS-1-like PTB domains.


Pssm-ID: 214675  Cd Length: 134  Bit Score: 93.92  E-value: 2.43e-22
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  1141 QGAACNVLFVNSVDMESLTGPQAISKATSETLAADP--TPAATIVHFKVSAQGITLTDNQRKlFFRRHYPLNTVTFCDLD 1218
Cdd:smart00462    2 SGVSFRVKYLGSVEVPEARGLQVVQEAIRKLRAAQGseKKEPQKVILSISSRGVKLIDEDTK-AVLHEHPLRRISFCAVG 80

                            90       100       110       120       130       140
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1907068278  1219 PQErkwmkteggapAKLFGFVARKQGStTDNACHLFAELDP--NQPASAIVNFVSKVMLSAGQKR 1281
Cdd:smart00462   81 PDD-----------LDVFGYIARDPGS-SRFACHVFRCEKAaeDIALAIGQAFQLAYELKLKARS 133
SH2 smart00252
Src homology 2 domains; Src homology 2 domains bind phosphotyrosine-containing polypeptides ...
 1009-1107 1.70e-12

Src homology 2 domains; Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae.


Pssm-ID: 214585 [Multi-domain]  Cd Length: 84  Bit Score: 64.17  E-value: 1.70e-12
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVssppptitqqgkkgdmtHELVRHFLIE-TGPRGVKLKGc 1087
Cdd:smart00252    3 WYHGFISREEAEKLLKNEGDGDFLVRDSESSPGDYVLSVRV-----------------KGKVKHYRIRrNEDGKFYLEG- 64

                            90       100
                    ....*....|....*....|..
gi 1907068278  1088 pnEPNFGSLSALV--YQHSVIP 1107
Cdd:smart00252   65 --GRKFPSLVELVehYQKNSLG 84
PHA03247 PHA03247
large tegument protein UL36; Provisional
 333-851 4.13e-09

large tegument protein UL36; Provisional


Pssm-ID: 223021 [Multi-domain]  Cd Length: 3151  Bit Score: 61.49  E-value: 4.13e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  333 PAGSNQSFHPKSPASSTFLPSPHSSAGP---QEPPASLPGLIAQPQLPPKETTSDPSRTPEEEPlnleglvahrvAVYNA 409
Cdd:PHA03247  2580 PAVTSRARRPDAPPQSARPRAPVDDRGDprgPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPP-----------PTVPP 2648

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  410 RLQSLRQSRGFQPSPHWRRSAslsgvQARERQPAEPPGPLRRRAAsdgqyenqsPEATSPRSPGVRSPVQCVSPELALTI 489
Cdd:PHA03247  2649 PERPRDDPAPGRVSRPRRARR-----LGRAAQASSPPQRPRRRAA---------RPTVGSLTSLADPPPPPPTPEPAPHA 2714

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  490 ALNPGGRPKEPhlhsykeafEEMEGTSPSSPPHSVARSPPGLAKTPLSAlgLKPHNPADILLHPTGEEDEGEEVTKPPEE 569
Cdd:PHA03247  2715 LVSATPLPPGP---------AAARQASPALPAAPAPPAVPAGPATPGGP--ARPARPPTTAGPPAPAPPAAPAAGPPRRL 2783

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  570 PRSYVESVARTAVAGPRAQDVEPKSFSAPAAHAyghetplrngtpggsfvspsplstssPILSADSTSVGSFPSVVSSDQ 649
Cdd:PHA03247  2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAA--------------------------ALPPAASPAGPLPPPTSAQPT 2837

                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  650 GPRTPFQPMLDSSIRSGSLGQPSPAALSYQSSSPVPVGGSSYNSPDYSLQ--PFSSSPESQGQPQYSAASvhmvPGSPQA 727
Cdd:PHA03247  2838 APPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLArpAVSRSTESFALPPDQPER----PPQPQA 2913

                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  728 RHRTVGTNTPPSPGFGRRAVnPTMAAPGSPSLSHRQVMGPSGPgfhgnvvsgHPASAATTPGSPSLGRHPVGSHQVPGLH 807
Cdd:PHA03247  2914 PPPPQPQPQPPPPPQPQPPP-PPPPRPQPPLAPTTDPAGAGEP---------SGAVPQPWLGALVPGRVAVPRFRVPQPA 2983

                          490       500       510       520
                   ....*....|....*....|....*....|....*....|....*
gi 1907068278  808 SSVVT-TPGSPSLGRHPGAHQGNLASSLHSNAVISPGSPSLGRHL 851
Cdd:PHA03247  2984 PSREApASSTPPLTGHSLSRVSSWASSLALHEETDPPPVSLKQTL 3028
SH2 pfam00017
SH2 domain;
1009-1103 1.44e-08

SH2 domain;


Pssm-ID: 425423 [Multi-domain]  Cd Length: 77  Bit Score: 52.60  E-value: 1.44e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLK-DQEPGAFIIRDSHSFRGAYGLAMKVssppptitqQGKkgdmthelVRHFLI-ETGPRGVKLKG 1086
Cdd:pfam00017    1 WYHGKISRQEAERLLLnGKPDGTFLVRESESTPGGYTLSVRD---------DGK--------VKHYKIqSTDNGGYYISG 63

                           90
                   ....*....|....*..
gi 1907068278 1087 cpnEPNFGSLSALVYQH 1103
Cdd:pfam00017   64 ---GVKFSSLAELVEHY 77
Herpes_BLLF1 pfam05109
Herpes virus major outer envelope glycoprotein (BLLF1); This family consists of the BLLF1 ...
 673-961 1.41e-03

Herpes virus major outer envelope glycoprotein (BLLF1); This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo.


Pssm-ID: 282904 [Multi-domain]  Cd Length: 886  Bit Score: 42.98  E-value: 1.41e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  673 PAALSYQSSSPVPVGGSSYNSP-DYSLQPFSSSPESQGQPQYSAASVHMVPgSPQARHRTVGTNTPP----SPGFGRRAV 747
Cdd:pfam05109  466 PTVSTADVTSPTPAGTTSGASPvTPSPSPRDNGTESKAPDMTSPTSAVTTP-TPNATSPTPAVTTPTpnatSPTLGKTSP 544

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  748 NPTMAAPGSPSLSHR-QVMGPSGPGFHGNVVSGHPASAATTPG----SPSLGRHP----VGSHQVPGLHSSVVTTPGSPS 818
Cdd:pfam05109  545 TSAVTTPTPNATSPTpAVTTPTPNATIPTLGKTSPTSAVTTPTpnatSPTVGETSpqanTTNHTLGGTSSTPVVTSPPKN 624

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  819 LGRHPGAHQGNLASSLHSNAVISPGSPSLGRHLGGSGSVVPGSPSLDRHAAYGGYSTpedrrpTLSRQSSASGYQAPSTp 898
Cdd:pfam05109  625 ATSAVTTGQHNITSSSTSSMSLRPSSISETLSPSTSDNSTSHMPLLTSAHPTGGENI------TQVTPASTSTHHVSTS- 697

                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1907068278  899 sfpvSPAYYPGLSSPATSPSPDSAAFRQG--SPTPALPEKRRMSVGDRAG---SLPNYATINGKVSSS 961
Cdd:pfam05109  698 ----SPAPRPGTTSQASGPGNSSTSTKPGevNVTKGTPPKNATSPQAPSGqktAVPTVTSTGGKANST 761
Chi1 COG3469
Chitinase [Carbohydrate transport and metabolism];
731-936 4.12e-03

Chitinase [Carbohydrate transport and metabolism];


Pssm-ID: 442692 [Multi-domain]  Cd Length: 534  Bit Score: 41.28  E-value: 4.12e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  731 TVGTNTPPSPGFGRRAVNPTMAAPGSPSLSHRQVMGPSGPGFHGNVVSGHPASAATTPGSPSLGRHPVGSHQVPGLHSSV 810
Cdd:COG3469      4 VSTAASPTAGGASATAVTLLGAAATAASVTLTAATATTVVSTTGSVVVAASGSAGSGTGTTAASSTAATSSTTSTTATAT 83

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  811 VTTPGSPSLGRHPGAHQGNLASSLHSNAVISPGSPSLGRHLGGSGSVVPGSPSLDRHAAYGGYSTPEDRRPTL------S 884
Cdd:COG3469     84 AAAAAATSTSATLVATSTASGANTGTSTVTTTSTGAGSVTSTTSSTAGSTTTSGASATSSAGSTTTTTTVSGTetatggT 163

                          170       180       190       200       210
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1907068278  885 RQSSASGYQAPSTPSFPVSPAYYPGLSSPATSPSPDSAAFRQGSPTPALPEK 936
Cdd:COG3469    164 TTTSTTTTTTSASTTPSATTTATATTASGATTPSATTTATTTGPPTPGLPKH 215
 
Name Accession Description Interval E-value
PTB_tensin cd01213
Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which ...
 1142-1275 7.13e-87

Tensin Phosphotyrosine-binding (PTB) domain; Tensin is a a focal adhesion protein, which contains a C-terminal SH2 domain followed by a PTB domain. PTB domains have a common PH-like fold and are found in various eukaryotic signaling molecules. This domain was initially shown to binds peptides with a NPXY motif with differing requirements for phosphorylation of the tyrosine, although more recent studies have found that some types of PTB domains can bind to peptides lack tyrosine residues altogether. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. PTB domains are classified into three groups: phosphotyrosine-dependent Shc-like, phosphotyrosine-dependent IRS-like, and phosphotyrosine-independent Dab-like PTB domains. This cd is part of the Dab-like subgroup.


Pssm-ID: 269924  Cd Length: 136  Bit Score: 277.59  E-value: 7.13e-87
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1142 GAACNVLFVNSVDMESLTGPQAISKATSETLAADPTPAATIVHFKVSAQGITLTDNQRKLFFRRHYPLNTVTFCDLDPQE 1221
Cdd:cd01213      1 GAACNVLYLGSVDTESLTGPQAVRKAVSETLERDPLPTPTVVHFKVSEQGITLTDNQRKLFFRRHYPLNTVSFCGMDPEN 80

                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1907068278 1222 RKWMKTE--GGAPAKLFGFVARKQGSTTDNACHLFAELDPNQPASAIVNFVSKVML 1275
Cdd:cd01213     81 RKWQKYDlrGSKPSRIFGFVARKQGSSTENVCHLFAELDPEQPASAIVNFVNKVLL 136
SH2_Tensin_like cd09927
Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. ...
 1005-1120 9.46e-67

Src homology 2 domain found in Tensin-like proteins; SH2 domain found in Tensin-like proteins. The Tensins are a family of intracellular proteins that interact with receptor tyrosine kinases (RTKs), integrins, and actin. They are thought act as signaling bridges between the extracellular space and the cytoskeleton. There are four homologues: Tensin1, Tensin2 (TENC1, C1-TEN), Tensin3 and Tensin4 (cten), all of which contain a C-terminal tandem SH2-PTB domain pairing, as well as actin-binding regions that may localize them to focal adhesions. The isoforms of Tensin2 and Tensin3 contain N-terminal C1 domains, which are atypical and not expected to bind to phorbol esters. Tensins 1-3 contain a phosphatase (PTPase) and C2 domain pairing which resembles PTEN (phosphatase and tensin homologue deleted on chromosome 10) protein. PTEN is a lipid phosphatase that dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to yield phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). As PtdIns(3,4,5)P3 is the product of phosphatidylinositol 3-kinase (PI3K) activity, PTEN is therefore a key negative regulator of the PI3K pathway. Because of their PTEN-like domains, the Tensins may also possess phosphoinositide-binding or phosphatase capabilities. However, only Tensin2 and Tensin3 have the potential to be phosphatases since only their PTPase domains contain a cysteine residue that is essential for catalytic activity. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198181 [Multi-domain]  Cd Length: 116  Bit Score: 220.38  E-value: 9.46e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1005 TSKYWYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVSSPPPTITQQGKKGDMTHELVRHFLIETGPRGVKL 1084
Cdd:cd09927      1 TSKYWYKPNISRDQAIALLKDKPPGTFLVRDSTTYKGAYGLAVKVATPPPGVNPFEAKGDPESELVRHFLIEPSPKGVKL 80

                           90       100       110
                   ....*....|....*....|....*....|....*.
gi 1907068278 1085 KGCPNEPNFGSLSALVYQHSVIPLALPCKLVIPSRD 1120
Cdd:cd09927     81 KGCPNEPVFGSLSALVYQHSITPLALPCKLRIPDRD 116
PTB pfam08416
Phosphotyrosine-binding domain; The phosphotyrosine-binding domain (PTB, also ...
 1144-1280 1.40e-37

Phosphotyrosine-binding domain; The phosphotyrosine-binding domain (PTB, also phosphotyrosine-interaction or PI domain) in the protein tensin tends to be found at the C-terminus. Tensin is a multi-domain protein that binds to actin filaments and functions as a focal-adhesion molecule (focal adhesions are regions of plasma membrane through which cells attach to the extracellular matrix). Human tensin has actin-binding sites, an SH2 (pfam00017) domain and a region similar to the tumour suppressor PTEN. The PTB domain interacts with the cytoplasmic tails of beta integrin by binding to an NPXY motif.


Pssm-ID: 429984  Cd Length: 131  Bit Score: 137.48  E-value: 1.40e-37
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1144 ACNVLFVNSVDMESLTGPQAISKAT--SETLAADPTPAATIVHFKVSAQGITLTDNQRKLFFrRHYPLNTVTFCDLDPQE 1221
Cdd:pfam08416    1 QYRVEHLTTFELDSLTGLQAVEDAIrkLQLLDAQGRVWTQEMLLQVSDQGITLTDNETKEEL-ESYPLDSISHCQAVLND 79

                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1907068278 1222 RKWmkteggapAKLFGFVARKQGSTTDNAcHLFA--ELDPNQPASAIVNFVSKVMLSAGQK 1280
Cdd:pfam08416   80 GRY--------NSILALVCQEPGQSKPDV-HLFQcdELGAELIAEDIESALSDVRLGKPKK 131
PTB smart00462
Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain; PTB/PI domain ...
 1141-1281 2.43e-22

Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain; PTB/PI domain structure similar to those of pleckstrin homology (PH) and IRS-1-like PTB domains.


Pssm-ID: 214675  Cd Length: 134  Bit Score: 93.92  E-value: 2.43e-22
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  1141 QGAACNVLFVNSVDMESLTGPQAISKATSETLAADP--TPAATIVHFKVSAQGITLTDNQRKlFFRRHYPLNTVTFCDLD 1218
Cdd:smart00462    2 SGVSFRVKYLGSVEVPEARGLQVVQEAIRKLRAAQGseKKEPQKVILSISSRGVKLIDEDTK-AVLHEHPLRRISFCAVG 80

                            90       100       110       120       130       140
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1907068278  1219 PQErkwmkteggapAKLFGFVARKQGStTDNACHLFAELDP--NQPASAIVNFVSKVMLSAGQKR 1281
Cdd:smart00462   81 PDD-----------LDVFGYIARDPGS-SRFACHVFRCEKAaeDIALAIGQAFQLAYELKLKARS 133
SH2 cd00173
Src homology 2 (SH2) domain; In general, SH2 domains are involved in signal transduction; they ...
 1009-1103 1.02e-15

Src homology 2 (SH2) domain; In general, SH2 domains are involved in signal transduction; they bind pTyr-containing polypeptide ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. They are present in a wide array of proteins including: adaptor proteins (Nck1, Crk, Grb2), scaffolds (Slp76, Shc, Dapp1), kinases (Src, Syk, Fps, Tec), phosphatases (Shp-1, Shp-2), transcription factors (STAT1), Ras signaling molecules (Ras-Gap), ubiquitination factors (c-Cbl), cytoskeleton regulators (Tensin), signal regulators (SAP), and phospholipid second messengers (PLCgamma), amongst others.


Pssm-ID: 198173 [Multi-domain]  Cd Length: 79  Bit Score: 73.26  E-value: 1.02e-15
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKvssppptiTQQGKkgdmthelVRHFLIETGPRGVKLKGCP 1088
Cdd:cd00173      2 WFHGSISREEAERLLRGKPDGTFLVRESSSEPGDYVLSVR--------SGDGK--------VKHYLIERNEGGYYLLGGS 65

                           90
                   ....*....|....*
gi 1907068278 1089 NEPnFGSLSALVYQH 1103
Cdd:cd00173     66 GRT-FPSLPELVEHY 79
SH2 smart00252
Src homology 2 domains; Src homology 2 domains bind phosphotyrosine-containing polypeptides ...
 1009-1107 1.70e-12

Src homology 2 domains; Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae.


Pssm-ID: 214585 [Multi-domain]  Cd Length: 84  Bit Score: 64.17  E-value: 1.70e-12
                            10        20        30        40        50        60        70        80
                    ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVssppptitqqgkkgdmtHELVRHFLIE-TGPRGVKLKGc 1087
Cdd:smart00252    3 WYHGFISREEAEKLLKNEGDGDFLVRDSESSPGDYVLSVRV-----------------KGKVKHYRIRrNEDGKFYLEG- 64

                            90       100
                    ....*....|....*....|..
gi 1907068278  1088 pnEPNFGSLSALV--YQHSVIP 1107
Cdd:smart00252   65 --GRKFPSLVELVehYQKNSLG 84
PTB cd00934
Phosphotyrosine-binding (PTB) PH-like fold; PTB domains have a common PH-like fold and are ...
 1145-1274 1.60e-10

Phosphotyrosine-binding (PTB) PH-like fold; PTB domains have a common PH-like fold and are found in various eukaryotic signaling molecules. This domain was initially shown to bind peptides with a NPXY motif with differing requirements for phosphorylation of the tyrosine, although more recent studies have found that some types of PTB domains can bind to peptides lack tyrosine residues altogether. In contrast to SH2 domains, which recognize phosphotyrosine and adjacent carboxy-terminal residues, PTB-domain binding specificity is conferred by residues amino-terminal to the phosphotyrosine. PTB domains are classified into three groups: phosphotyrosine-dependent Shc-like, phosphotyrosine-dependent IRS-like, and phosphotyrosine-independent Dab-like PTB domains.


Pssm-ID: 269911  Cd Length: 120  Bit Score: 59.83  E-value: 1.60e-10
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1145 CNVLFVNSVDMESLTGPQAISKATSETLAAD--PTPAATIVHFKVSAQGITLTDNQRKLFFRRHyPLNTVTFCDLDPQER 1222
Cdd:cd00934      3 FQVKYLGSVEVGSSRGVDVVEEALKALAAALksSKRKPGPVLLEVSSKGVKLLDLDTKELLLRH-PLHRISYCGRDPDNP 81

                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1907068278 1223 kwmkteggapaKLFGFVARKQGStTDNACHLFAELDPnQPASAIVNFVSKVM 1274
Cdd:cd00934     82 -----------NVFAFIAGEEGG-SGFRCHVFQCEDE-EEAEEILQAIGQAF 120
PHA03247 PHA03247
large tegument protein UL36; Provisional
 333-851 4.13e-09

large tegument protein UL36; Provisional


Pssm-ID: 223021 [Multi-domain]  Cd Length: 3151  Bit Score: 61.49  E-value: 4.13e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  333 PAGSNQSFHPKSPASSTFLPSPHSSAGP---QEPPASLPGLIAQPQLPPKETTSDPSRTPEEEPlnleglvahrvAVYNA 409
Cdd:PHA03247  2580 PAVTSRARRPDAPPQSARPRAPVDDRGDprgPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPP-----------PTVPP 2648

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  410 RLQSLRQSRGFQPSPHWRRSAslsgvQARERQPAEPPGPLRRRAAsdgqyenqsPEATSPRSPGVRSPVQCVSPELALTI 489
Cdd:PHA03247  2649 PERPRDDPAPGRVSRPRRARR-----LGRAAQASSPPQRPRRRAA---------RPTVGSLTSLADPPPPPPTPEPAPHA 2714

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  490 ALNPGGRPKEPhlhsykeafEEMEGTSPSSPPHSVARSPPGLAKTPLSAlgLKPHNPADILLHPTGEEDEGEEVTKPPEE 569
Cdd:PHA03247  2715 LVSATPLPPGP---------AAARQASPALPAAPAPPAVPAGPATPGGP--ARPARPPTTAGPPAPAPPAAPAAGPPRRL 2783

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  570 PRSYVESVARTAVAGPRAQDVEPKSFSAPAAHAyghetplrngtpggsfvspsplstssPILSADSTSVGSFPSVVSSDQ 649
Cdd:PHA03247  2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAA--------------------------ALPPAASPAGPLPPPTSAQPT 2837

                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  650 GPRTPFQPMLDSSIRSGSLGQPSPAALSYQSSSPVPVGGSSYNSPDYSLQ--PFSSSPESQGQPQYSAASvhmvPGSPQA 727
Cdd:PHA03247  2838 APPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLArpAVSRSTESFALPPDQPER----PPQPQA 2913

                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  728 RHRTVGTNTPPSPGFGRRAVnPTMAAPGSPSLSHRQVMGPSGPgfhgnvvsgHPASAATTPGSPSLGRHPVGSHQVPGLH 807
Cdd:PHA03247  2914 PPPPQPQPQPPPPPQPQPPP-PPPPRPQPPLAPTTDPAGAGEP---------SGAVPQPWLGALVPGRVAVPRFRVPQPA 2983

                          490       500       510       520
                   ....*....|....*....|....*....|....*....|....*
gi 1907068278  808 SSVVT-TPGSPSLGRHPGAHQGNLASSLHSNAVISPGSPSLGRHL 851
Cdd:PHA03247  2984 PSREApASSTPPLTGHSLSRVSSWASSLALHEETDPPPVSLKQTL 3028
SH2 pfam00017
SH2 domain;
1009-1103 1.44e-08

SH2 domain;


Pssm-ID: 425423 [Multi-domain]  Cd Length: 77  Bit Score: 52.60  E-value: 1.44e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLK-DQEPGAFIIRDSHSFRGAYGLAMKVssppptitqQGKkgdmthelVRHFLI-ETGPRGVKLKG 1086
Cdd:pfam00017    1 WYHGKISRQEAERLLLnGKPDGTFLVRESESTPGGYTLSVRD---------DGK--------VKHYKIqSTDNGGYYISG 63

                           90
                   ....*....|....*..
gi 1907068278 1087 cpnEPNFGSLSALVYQH 1103
Cdd:pfam00017   64 ---GVKFSSLAELVEHY 77
PHA03247 PHA03247
large tegument protein UL36; Provisional
 440-972 3.54e-08

large tegument protein UL36; Provisional


Pssm-ID: 223021 [Multi-domain]  Cd Length: 3151  Bit Score: 58.41  E-value: 3.54e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  440 RQPAEPPGPLRRRAASD-GQYENQSPEAtsPRSPGVRSPVqcvspelalTIALNPGGRPKEPHLHSYKEAFEEMEGTSPS 518
Cdd:PHA03247  2481 RRPAEARFPFAAGAAPDpGGGGPPDPDA--PPAPSRLAPA---------ILPDEPVGEPVHPRMLTWIRGLEELASDDAG 2549

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  519 SPPHSVARSPPGLA---KTPLSALGLKPHNPAdillhpTGEEDEGEEVTKPPEEPRSYVE---SVARTAVAGPRAQDVEP 592
Cdd:PHA03247  2550 DPPPPLPPAAPPAApdrSVPPPRPAPRPSEPA------VTSRARRPDAPPQSARPRAPVDdrgDPRGPAPPSPLPPDTHA 2623

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  593 KSFSAPAAHAYGHETPLRNGTPGGSFVSPSPLSTSSPI-LSADSTSVGSFPSVVSSDQGPRTPFQPMLDSSIRSGSL--- 668
Cdd:PHA03247  2624 PDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVsRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADppp 2703

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  669 --GQPSPAALSYQSSSPVPVGgssynsPDYSLQPFSSSPESQGQPQYSAASVhmVPGSPQARHRTVGTNTPPSPGFGRRA 746
Cdd:PHA03247  2704 ppPTPEPAPHALVSATPLPPG------PAAARQASPALPAAPAPPAVPAGPA--TPGGPARPARPPTTAGPPAPAPPAAP 2775

                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  747 VNPTMAAPGSPSLSHRQVMGPSGPgfhgnvvSGHPASAATTPGSPSLGRHPVGSHQVPGLHSSVVTTPGSPSLGRHPgah 826
Cdd:PHA03247  2776 AAGPPRRLTRPAVASLSESRESLP-------SPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGP--- 2845

                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  827 qgnLASSLHSNAVISPGSPSLGRHLGGSGSVVPGSPSL----------------------DRHAAYGGYSTPEDRRPTLS 884
Cdd:PHA03247  2846 ---PPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARppvrrlarpavsrstesfalppDQPERPPQPQAPPPPQPQPQ 2922

                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  885 RQSSASGYQAPSTPSFPVSPAYYPGLSSPATSPSPDSAAFRQGSPTPALPEKRRMSVGDRAGSLPNYATINGKVSSSPVA 964
Cdd:PHA03247  2923 PPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLS 3002


                   ....*...
gi 1907068278  965 NGMASGSS 972
Cdd:PHA03247  3003 RVSSWASS 3010
PHA03307 PHA03307
transcriptional regulator ICP4; Provisional
 613-938 9.08e-05

transcriptional regulator ICP4; Provisional


Pssm-ID: 223039 [Multi-domain]  Cd Length: 1352  Bit Score: 47.09  E-value: 9.08e-05
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  613 TPGGSFVSPSPLSTSSPILSADSTSVGSFPSVVSSDQGPRTPFQPMLDSSIRSGSLGQPSPAALSYQSSSPVPVGGSSYN 692
Cdd:PHA03307    72 PPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAAS 151

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  693 SPDyslQPFSSSPESQGQPQYSAASVhmVPGSPQARHRTVGTNTPPSPGFGRRAVNPTMAAPGSPSLSHRQVMGPSGPGF 772
Cdd:PHA03307   152 PPA---AGASPAAVASDAASSRQAAL--PLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGR 226

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  773 HGNvvSGHPASAATTPGSPSLGRHPVGSHQVPGLHSSVVTTPGSPSLGrHPGAHQGNLASSLHSNAVISPGSPSLGRHLG 852
Cdd:PHA03307   227 SAA--DDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEA-SGWNGPSSRPGPASSSSSPRERSPSPSPSSP 303

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  853 GSGSVVPGSPSLDRHAAYGGYSTPEDRRPTLSRQSSASGYQAPSTPSFPVSPAYYPGLSSPATSPSPDSAAFRQGSPTPA 932
Cdd:PHA03307   304 GSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAG 383


                   ....*.
gi 1907068278  933 LPEKRR 938
Cdd:PHA03307   384 RPTRRR 389
PHA03247 PHA03247
large tegument protein UL36; Provisional
 156-539 1.60e-04

large tegument protein UL36; Provisional


Pssm-ID: 223021 [Multi-domain]  Cd Length: 3151  Bit Score: 46.47  E-value: 1.60e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  156 DPSGLFRSQSFPDVEPQLPQAPTRGGSSREAVQRGLNSWQQQQPHPPPRQQER---SPLQSLARSKPSPQLSAETPVAAL 232
Cdd:PHA03247  2637 EPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARptvGSLTSLADPPPPPPTPEPAPHALV 2716

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  233 PEFPRAASQQEIEQSIETLNmlmldLEPASAAAPLHKSQSVPGAWPGASPLSSQPLLGSSRQSHPLTQSRSGYIPSGHSL 312
Cdd:PHA03247  2717 SATPLPPGPAAARQASPALP-----AAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASL 2791

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  313 GtpelVSSGRPYSPYDYQLHPAGSnqsfhpksPASSTFLPSPHSSAGPQEPPASlpgliAQPQLPPkettsdPSRTPEEE 392
Cdd:PHA03247  2792 S----ESRESLPSPWDPADPPAAV--------LAPAAALPPAASPAGPLPPPTS-----AQPTAPP------PPPGPPPP 2848

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  393 PLNLEGLVAHRVAV-YNARLQSLRQSRGFQPSPHWRRSASLSGVQARERQPAEPPGPLRRRAASDGQYENQSPEATSPRS 471
Cdd:PHA03247  2849 SLPLGGSVAPGGDVrRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQ 2928

                          330       340       350       360       370       380       390
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1907068278  472 PGVRSPVQCVS-PELALTIALNPGGRPKEP-------HLHSYKEAFEEMEGTSPSSPPHSVARSPPGLAKTPLSAL 539
Cdd:PHA03247  2929 PQPPPPPPPRPqPPLAPTTDPAGAGEPSGAvpqpwlgALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRV 3004
SH2_Tec_family cd09934
Src homology 2 (SH2) domain found in Tec-like proteins; The Tec protein tyrosine kinase is the ...
 1007-1117 1.99e-04

Src homology 2 (SH2) domain found in Tec-like proteins; The Tec protein tyrosine kinase is the founding member of a family that includes Btk, Itk, Bmx, and Txk. The members have a PH domain, a zinc-binding motif, a SH3 domain, a SH2 domain, and a protein kinase catalytic domain. Btk is involved in B-cell receptor signaling with mutations in Btk responsible for X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Itk is involved in T-cell receptor signaling. Tec is expressed in both T and B cells, and is thought to function in activated and effector T lymphocytes to induce the expression of genes regulated by NFAT transcription factors. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198188  Cd Length: 104  Bit Score: 42.00  E-value: 1.99e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1007 KY-WYKPEISREQAIALLKDQ-EPGAFIIRDShSFRGAYGLA--MKVSSPPptitqqgkkgdmtheLVRHFLIETGPRG- 1081
Cdd:cd09934      5 KYeWYVGDMSRQRAESLLKQEdKEGCFVVRNS-STKGLYTVSlfTKVPGSP---------------HVKHYHIKQNARSe 68

                           90       100       110
                   ....*....|....*....|....*....|....*...
gi 1907068278 1082 --VKLKGCpnepnFGSLSALVYQHSVIPLALPCKLVIP 1117
Cdd:cd09934     69 fyLAEKHC-----FETIPELINYHQHNSGGLATRLKYP 101
SH2_Grb2_like cd09941
Src homology 2 domain found in Growth factor receptor-bound protein 2 (Grb2) and similar ...
 1009-1106 2.23e-04

Src homology 2 domain found in Growth factor receptor-bound protein 2 (Grb2) and similar proteins; The adaptor proteins here include homologs Grb2 in humans, Sex muscle abnormal protein 5 (Sem-5) in Caenorhabditis elegans, and Downstream of receptor kinase (drk) in Drosophila melanogaster. They are composed of one SH2 and two SH3 domains. Grb2/Sem-5/drk regulates the Ras pathway by linking the tyrosine kinases to the Ras guanine nucleotide releasing protein Sos, which converts Ras to the active GTP-bound state. The SH2 domain of Grb2/Sem-5/drk binds class II phosphotyrosyl peptides while its SH3 domain binds to Sos and Sos-derived, proline-rich peptides. Besides it function in Ras signaling, Grb2 is also thought to play a role in apoptosis. Unlike most SH2 structures in which the peptide binds in an extended conformation (such that the +3 peptide residue occupies a hydrophobic pocket in the protein, conferring a modest degree of selectivity), Grb2 forms several hydrogen bonds via main chain atoms with the side chain of +2 Asn. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 199828  Cd Length: 95  Bit Score: 41.49  E-value: 2.23e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLKDQEP-GAFIIRDSHSFRGAYGLAMKVssppptitqqgkkgdmtHELVRHFLIETGPRG------ 1081
Cdd:cd09941      5 WFHGKISRAEAEEILMNQRPdGAFLIRESESSPGDFSLSVKF-----------------GNDVQHFKVLRDGAGkyflwv 67

                           90       100
                   ....*....|....*....|....*..
gi 1907068278 1082 VKlkgcpnepnFGSLSALV--YQHSVI 1106
Cdd:cd09941     68 VK---------FNSLNELVdyHRTTSV 85
SH2_Srm cd10360
Src homology 2 (SH2) domain found in Src-related kinase lacking C-terminal regulatory tyrosine ...
 1009-1048 4.18e-04

Src homology 2 (SH2) domain found in Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites (srm); Srm is a nonreceptor protein kinase that has two SH2 domains, a SH3 domain, and a kinase domain with a tyrosine residue for autophosphorylation. However it lacks an N-terminal glycine for myristoylation and a C-terminal tyrosine which suppresses kinase activity when phosphorylated. Srm is most similar to members of the Tec family who other members include: Tec, Btk/Emb, and Itk/Tsk/Emt. However Srm differs in its N-terminal unique domain it being much smaller than in the Tec family and is closer to Src. Srm is thought to be a new family of nonreceptor tyrosine kinases that may be redundant in function. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198223  Cd Length: 79  Bit Score: 40.32  E-value: 4.18e-04
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|..
gi 1907068278 1009 WYKPEISREQAIALL--KDQEPGAFIIRDSHSFRGAYGLAMK 1048
Cdd:cd10360      2 WYFSGISRTQAQQLLlsPPNEPGAFLIRPSESSLGGYSLSVR 43
SH2_ABL cd09935
Src homology 2 (SH2) domain found in Abelson murine lymphosarcoma virus (ABL) proteins; ...
 1009-1117 4.69e-04

Src homology 2 (SH2) domain found in Abelson murine lymphosarcoma virus (ABL) proteins; ABL-family proteins are highly conserved tyrosine kinases. Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity and is common among nonreceptor tyrosine kinases. Several types of posttranslational modifications control ABL catalytic activity, subcellular localization, and stability, with consequences for both cytoplasmic and nuclear ABL functions. Binding partners provide additional regulation of ABL catalytic activity, substrate specificity, and downstream signaling. By combining this cassette with actin-binding and -bundling domain, ABL proteins are capable of connecting phosphoregulation with actin-filament reorganization. Vertebrate paralogs, ABL1 and ABL2, have evolved to perform specialized functions. ABL1 includes nuclear localization signals and a DNA binding domain which is used to mediate DNA damage-repair functions, while ABL2 has additional binding capacity for actin and for microtubules to enhance its cytoskeletal remodeling functions. SH2 is involved in several autoinhibitory mechanism that constrain the enzymatic activity of the ABL-family kinases. In one mechanism SH2 and SH3 cradle the kinase domain while a cap sequence stabilizes the inactive conformation resulting in a locked inactive state. Another involves phosphatidylinositol 4,5-bisphosphate (PIP2) which binds the SH2 domain through residues normally required for phosphotyrosine binding in the linker segment between the SH2 and kinase domains. The SH2 domain contributes to ABL catalytic activity and target site specificity. It is thought that the ABL catalytic site and SH2 pocket have coevolved to recognize the same sequences. Recent work now supports a hierarchical processivity model in which the substrate target site most compatible with ABL kinase domain preferences is phosphorylated with greatest efficiency. If this site is compatible with the ABL SH2 domain specificity, it will then reposition and dock in the SH2 pocket. This mechanism also explains how ABL kinases phosphorylates poor targets on the same substrate if they are properly positioned and how relatively poor substrate proteins might be recruited to ABL through a complex with strong substrates that can also dock with the SH2 pocket. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198189  Cd Length: 94  Bit Score: 40.45  E-value: 4.69e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVssppptitqqgkkgdmtHELVRHFLIETGPRGvKLKGCP 1088
Cdd:cd09935      5 WYHGPISRNAAEYLLSSGINGSFLVRESESSPGQYSISLRY-----------------DGRVYHYRISEDSDG-KVYVTQ 66

                           90       100
                   ....*....|....*....|....*....
gi 1907068278 1089 NEPnFGSLSALVYQHSVIPLALPCKLVIP 1117
Cdd:cd09935     67 EHR-FNTLAELVHHHSKNADGLITTLRYP 94
SH2_Nterm_shark_like cd10347
N-terminal Src homology 2 (SH2) domain found in SH2 domains, ANK, and kinase domain (shark) ...
 1009-1047 4.85e-04

N-terminal Src homology 2 (SH2) domain found in SH2 domains, ANK, and kinase domain (shark) proteins; These non-receptor protein-tyrosine kinases contain two SH2 domains, five ankyrin (ANK)-like repeats, and a potential tyrosine phosphorylation site in the carboxyl-terminal tail which resembles the phosphorylation site in members of the src family. Like, mammalian non-receptor protein-tyrosine kinases, ZAP-70 and syk proteins, they do not have SH3 domains. However, the presence of ANK makes these unique among protein-tyrosine kinases. Both tyrosine kinases and ANK repeats have been shown to transduce developmental signals, and SH2 domains are known to participate intimately in tyrosine kinase signaling. These tyrosine kinases are believed to be involved in epithelial cell polarity. The members of this family include the shark (SH2 domains, ANK, and kinase domain) gene in Drosophila and yellow fever mosquitos, as well as the hydra protein HTK16. Drosophila Shark is proposed to transduce intracellularly the Crumbs, a protein necessary for proper organization of ectodermal epithelia, intercellular signal. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198210  Cd Length: 81  Bit Score: 40.05  E-value: 4.85e-04
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|.
gi 1907068278 1009 WYKPEISREQAIALLKDQEP--GAFIIRDSHSFRGAYGLAM 1047
Cdd:cd10347      3 WYHGKISREVAEALLLREGGrdGLFLVRESTSAPGDYVLSL 43
SH2_BLNK_SLP-76 cd09929
Src homology 2 (SH2) domain found in B-cell linker (BLNK) protein and SH2 domain-containing ...
 1006-1125 4.86e-04

Src homology 2 (SH2) domain found in B-cell linker (BLNK) protein and SH2 domain-containing leukocyte protein of 76 kDa (SLP-76); BLNK (also known as SLP-65 or BASH) is an important adaptor protein expressed in B-lineage cells. BLNK consists of a N-terminal sterile alpha motif (SAM) domain and a C-terminal SH2 domain. BLNK is a cytoplasmic protein, but a part of it is bound to the plasma membrane through an N-terminal leucine zipper motif and transiently bound to a cytoplasmic domain of Iga through its C-terminal SH2 domain upon B cell antigen receptor (BCR)-stimulation. A non-ITAM phosphotyrosine in Iga is necessary for the binding with the BLNK SH2 domain and/or for normal BLNK function in signaling and B cell activation. Upon phosphorylation BLNK binds Btk and PLCgamma2 through their SH2 domains and mediates PLCgamma2 activation by Btk. BLNK also binds other signaling molecules such as Vav, Grb2, Syk, and HPK1. BLNK has been shown to be necessary for BCR-mediated Ca2+ mobilization, for the activation of mitogen-activated protein kinases such as ERK, JNK, and p38 in a chicken B cell line DT40, and for activation of transcription factors such as NF-AT and NF-kappaB in human or mouse B cells. BLNK is involved in B cell development, B cell survival, activation, proliferation, and T-independent immune responses. BLNK is structurally homologous to SLP-76. SLP-76 and (linker for activation of T cells) LAT are adaptor/linker proteins in T cell antigen receptor activation and T cell development. BLNK interacts with many downstream signaling proteins that interact directly with both SLP-76 and LAT. New data suggest functional complementation of SLP-76 and LAT in T cell antigen receptor function with BLNK in BCR function. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198183  Cd Length: 121  Bit Score: 41.15  E-value: 4.86e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1006 SKYWYKPEISREQA-IALLKDQEPGAFIIRDS--HSFRGAYGLAM----KVSSPPptITQQGKKgdmthelvRHFLIETG 1078
Cdd:cd09929     10 PKEWYAGNIDRKEAeEALRRSNKDGTFLVRDSsgKDSSQPYTLMVlyndKVYNIQ--IRFLENT--------RQYALGTG 79

                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....*..
gi 1907068278 1079 PRGvklkgcpnEPNFGSLSALVYQHSVIPLALpcklvIPSRDPTDES 1125
Cdd:cd09929     80 LRG--------EETFSSVAEIIEHHQKTPLLL-----IDGKDNTKDS 113
PTZ00449 PTZ00449
104 kDa microneme/rhoptry antigen; Provisional
 342-597 8.65e-04

104 kDa microneme/rhoptry antigen; Provisional


Pssm-ID: 185628 [Multi-domain]  Cd Length: 943  Bit Score: 43.91  E-value: 8.65e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  342 PKSPASSTFLPSP--HSSAGPQEPPASLPGLIAQPQLPPKET-----TSDPSRTPEEEPlnleglvaHRVAVYNARLQSL 414
Cdd:PTZ00449   511 PEGPEASGLPPKApgDKEGEEGEHEDSKESDEPKEGGKPGETkegevGKKPGPAKEHKP--------SKIPTLSKKPEFP 582

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  415 RQSRgfqpSPHWRRSASLSGVQARERQPAEPPGPLRRRAASDGQYENQSPEATSPRSPgvRSPVQCVSPELALTIAL--- 491
Cdd:PTZ00449   583 KDPK----HPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRP--PPPQRPSSPERPEGPKIiks 656

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  492 -NPGGRPKEPHLHSYKEAF----------------------------EEMEGTSPSSPPHSVARSPPGLAKTPLSalglk 542
Cdd:PTZ00449   657 pKPPKSPKPPFDPKFKEKFyddyldaaaksketkttvvldesfesilKETLPETPGTPFTTPRPLPPKLPRDEEF----- 731

                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1907068278  543 PHNPADillHPTGEEDEGEEVTKPPEEPRSYV-ESVARTAVAGPRAQDVEPKSFSA 597
Cdd:PTZ00449   732 PFEPIG---DPDAEQPDDIEFFTPPEEERTFFhETPADTPLPDILAEEFKEEDIHA 784
SH2_nSH2_p85_like cd09942
N-terminal Src homology 2 (nSH2) domain found in p85; Phosphoinositide 3-kinases (PI3Ks) are ...
 1009-1048 1.01e-03

N-terminal Src homology 2 (nSH2) domain found in p85; Phosphoinositide 3-kinases (PI3Ks) are essential for cell growth, migration, and survival. p110, the catalytic subunit, is composed of an adaptor-binding domain, a Ras-binding domain, a C2 domain, a helical domain, and a kinase domain. The regulatory unit is called p85 and is composed of an SH3 domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain, an internal SH2 (iSH2) domain, and C-terminal (cSH2) domain. There are 2 inhibitory interactions between p110alpha and p85 of P13K: (1) p85 nSH2 domain with the C2, helical, and kinase domains of p110alpha and (2) p85 iSH2 domain with C2 domain of p110alpha. There are 3 inhibitory interactions between p110beta and p85 of P13K: (1) p85 nSH2 domain with the C2, helical, and kinase domains of p110beta, (2) p85 iSH2 domain with C2 domain of p110alpha, and (3) p85 cSH2 domain with the kinase domain of p110alpha. It is interesting to note that p110beta is oncogenic as a wild type protein while p110alpha lacks this ability. One explanation is the idea that the regulation of p110beta by p85 is unique because of the addition of inhibitory contacts from the cSH2 domain and the loss of contacts in the iSH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198195  Cd Length: 110  Bit Score: 40.00  E-value: 1.01e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMK 1048
Cdd:cd09942      9 WYWGDISREEVNEKMRDTPDGTFLVRDASTMKGDYTLTLR 48
PHA03307 PHA03307
transcriptional regulator ICP4; Provisional
 146-536 1.03e-03

transcriptional regulator ICP4; Provisional


Pssm-ID: 223039 [Multi-domain]  Cd Length: 1352  Bit Score: 43.62  E-value: 1.03e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  146 QQVTSAHCGCDPSGLFRSQSFPDVEPQLPQAPTRGGSSREAVQRGLNSWQQQQPHPPPRQQERSPLQSLARSK------P 219
Cdd:PHA03307    42 QLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPdpppptP 121

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  220 SPQLSAETPVAALPEFPRAASQQEIEQSIEtlnmlMLDLEPASAAAPLHKSQSVPGAWPGASPLSSQPLLGSSRQSHPLT 299
Cdd:PHA03307   122 PPASPPPSPAPDLSEMLRPVGSPGPPPAAS-----PPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPS 196

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  300 QSRSGYIPSGHSLGTPELVSSGRPYSpydyqLHPAGSNQSFHPKSPASSTFLPSPHSSAGPQEPPASLPGLIAQPQ---- 375
Cdd:PHA03307   197 TPPAAASPRPPRRSSPISASASSPAP-----APGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTriwe 271

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  376 -LPPKETTSDPSRTPEEEPLNLEGLVAHRVAVYNARLQSLRQSRGFQPSPHWRRSASLSGVQARERQPAEPPGPLRRRAA 454
Cdd:PHA03307   272 aSGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSP 351

                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  455 SDGqyenQSPEATSPRSPGVRSPVQCVSPELALTIA--LNPGGRPKEPHLHSYKEAFEEMEGT-SPSSPPHSVARSPPGL 531
Cdd:PHA03307   352 SPS----RPPPPADPSSPRKRPRPSRAPSSPAASAGrpTRRRARAAVAGRARRRDATGRFPAGrPRPSPLDAGAASGAFY 427


                   ....*
gi 1907068278  532 AKTPL 536
Cdd:PHA03307   428 ARYPL 432
PLN02217 PLN02217
probable pectinesterase/pectinesterase inhibitor
 767-890 1.26e-03

probable pectinesterase/pectinesterase inhibitor


Pssm-ID: 215130 [Multi-domain]  Cd Length: 670  Bit Score: 43.15  E-value: 1.26e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  767 PSGPGfhgnVVSGHPASAATTPGSPSLGRHPVGSHQVPglhSSVVTTPGSPslgrhPGAHQGNLASSlhSNAVISPGSPS 846
Cdd:PLN02217   556 PYIPG----LFAGNPGSTNSTPTGSAASSNTTFSSDSP---STVVAPSTSP-----PAGHLGSPPAT--PSKIVSPSTSP 621

                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....
gi 1907068278  847 LGRHLgGSGSVVPGSPSLDRHAAYGGYSTPEDRRPTLSRQSSAS 890
Cdd:PLN02217   622 PASHL-GSPSTTPSSPESSIKVASTETASPESSIKVASTESSVS 664
Herpes_BLLF1 pfam05109
Herpes virus major outer envelope glycoprotein (BLLF1); This family consists of the BLLF1 ...
 673-961 1.41e-03

Herpes virus major outer envelope glycoprotein (BLLF1); This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo.


Pssm-ID: 282904 [Multi-domain]  Cd Length: 886  Bit Score: 42.98  E-value: 1.41e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  673 PAALSYQSSSPVPVGGSSYNSP-DYSLQPFSSSPESQGQPQYSAASVHMVPgSPQARHRTVGTNTPP----SPGFGRRAV 747
Cdd:pfam05109  466 PTVSTADVTSPTPAGTTSGASPvTPSPSPRDNGTESKAPDMTSPTSAVTTP-TPNATSPTPAVTTPTpnatSPTLGKTSP 544

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  748 NPTMAAPGSPSLSHR-QVMGPSGPGFHGNVVSGHPASAATTPG----SPSLGRHP----VGSHQVPGLHSSVVTTPGSPS 818
Cdd:pfam05109  545 TSAVTTPTPNATSPTpAVTTPTPNATIPTLGKTSPTSAVTTPTpnatSPTVGETSpqanTTNHTLGGTSSTPVVTSPPKN 624

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  819 LGRHPGAHQGNLASSLHSNAVISPGSPSLGRHLGGSGSVVPGSPSLDRHAAYGGYSTpedrrpTLSRQSSASGYQAPSTp 898
Cdd:pfam05109  625 ATSAVTTGQHNITSSSTSSMSLRPSSISETLSPSTSDNSTSHMPLLTSAHPTGGENI------TQVTPASTSTHHVSTS- 697

                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1907068278  899 sfpvSPAYYPGLSSPATSPSPDSAAFRQG--SPTPALPEKRRMSVGDRAG---SLPNYATINGKVSSS 961
Cdd:pfam05109  698 ----SPAPRPGTTSQASGPGNSSTSTKPGevNVTKGTPPKNATSPQAPSGqktAVPTVTSTGGKANST 761
PTZ00395 PTZ00395
Sec24-related protein; Provisional
 661-824 1.80e-03

Sec24-related protein; Provisional


Pssm-ID: 185594 [Multi-domain]  Cd Length: 1560  Bit Score: 42.75  E-value: 1.80e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  661 SSIRSGSLGQpSPAALSYQSSSPVPVGGSSYNSPDYSLQPFSSSPESQ---GQPQYSAASVHMVPGSPQARHRTVGTNTP 737
Cdd:PTZ00395   395 SNAAQSNAAQ-SNAGFSNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNtpySNPPNSNPPYSNLPYSNTPYSNAPLSNAP 473

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  738 PSPGFGRRAVNPTmaapgspSLSHRQVMGPSGPGFHGNVVSGHP--ASAATTPGSPSLGRhPVGSHQVPGLHSSVVTTPG 815
Cdd:PTZ00395   474 PSSAKDHHSAYHA-------AYQHRAANQPAANLPTANQPAANNfhGAAGNSVGNPFASR-PFGSAPYGGNAATTADPNG 545


                   ....*....
gi 1907068278  816 SPSLGRHPG 824
Cdd:PTZ00395   546 IAKREDHPE 554
SH2_CRK_like cd09926
Src homology 2 domain found in cancer-related signaling adaptor protein CRK; SH2 domain in the ...
 1009-1051 2.00e-03

Src homology 2 domain found in cancer-related signaling adaptor protein CRK; SH2 domain in the CRK proteins. CRKI (SH2-SH3) and CRKII (SH2-SH3-SH3) are splicing isoforms of the oncoprotein CRK. CRKs regulate transcription and cytoskeletal reorganization for cell growth and motility by linking tyrosine kinases to small G proteins. The SH2 domain of CRK associates with tyrosine-phosphorylated receptors or components of focal adhesions, such as p130Cas and paxillin. CRK transmits signals to small G proteins through effectors that bind its SH3 domain, such as C3G, the guanine-nucleotide exchange factor (GEF) for Rap1 and R-Ras, and DOCK180, the GEF for Rac6. The binding of p130Cas to the CRK-C3G complex activates Rap1, leading to regulation of cell adhesion, and activates R-Ras, leading to JNK-mediated activation of cell proliferation, whereas the binding of CRK DOCK180 induces Rac1-mediated activation of cellular migration. The activity of the different splicing isoforms varies greatly with CRKI displaying substantial transforming activity, CRKII less so, and phosphorylated CRKII with no biological activity whatsoever. CRKII has a linker region with a phosphorylated Tyr and an additional C-terminal SH3 domain. The phosphorylated Tyr creates a binding site for its SH2 domain which disrupts the association between CRK and its SH2 target proteins. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198180 [Multi-domain]  Cd Length: 106  Bit Score: 38.99  E-value: 2.00e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|...
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMKVSS 1051
Cdd:cd09926      9 WYFGPMSRQEAQELLQGQRHGVFLVRDSSTIPGDYVLSVSENS 51
SH2_C-SH2_PLC_gamma_like cd09932
C-terminal Src homology 2 (C-SH2) domain in Phospholipase C gamma; Phospholipase C gamma is a ...
 1006-1049 2.06e-03

C-terminal Src homology 2 (C-SH2) domain in Phospholipase C gamma; Phospholipase C gamma is a signaling molecule that is recruited to the C-terminal tail of the receptor upon autophosphorylation of a highly conserved tyrosine. PLCgamma is composed of a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, 2 catalytic regions of PLC domains that flank 2 tandem SH2 domains (N-SH2, C-SH2), and ending with a SH3 domain and C2 domain. N-SH2 SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. Both N-SH2 and C-SH2 have a very similar binding affinity to pY. But in growth factor stimulated cells these domains bind to different target proteins. N-SH2 binds to pY containing sites in the C-terminal tails of tyrosine kinases and other receptors. Recently it has been shown that this interaction is mediated by phosphorylation-independent interactions between a secondary binding site found exclusively on the N-SH2 domain and a region of the FGFR1 tyrosine kinase domain. This secondary site on the SH2 cooperates with the canonical pY site to regulate selectivity in mediating a specific cellular process. C-SH2 binds to an intramolecular site on PLCgamma itself which allows it to hydrolyze phosphatidylinositol-4,5-bisphosphate into diacylglycerol and inositol triphosphate. These then activate protein kinase C and release calcium. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198186  Cd Length: 104  Bit Score: 39.17  E-value: 2.06e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....*
gi 1907068278 1006 SKYWYKPEISREQAIALLKD-QEPGAFIIRDSHSFRGAYGLAMKV 1049
Cdd:cd09932      3 SKEWFHANLTREQAEEMLMRvPRDGAFLVRPSETDPNSFAISFRA 47
SH2_Grb7_family cd09944
Src homology 2 (SH2) domain found in the growth factor receptor bound, subclass 7 (Grb7) ...
 1006-1048 2.34e-03

Src homology 2 (SH2) domain found in the growth factor receptor bound, subclass 7 (Grb7) proteins; The Grb family binds to the epidermal growth factor receptor (EGFR, erbB1) via their SH2 domains. There are 3 members of the Grb7 family of proteins: Grb7, Grb10, and Grb14. They are composed of an N-terminal Proline-rich domain, a Ras Associating-like (RA) domain, a Pleckstrin Homology (PH) domain, a phosphotyrosine interaction region (PIR, BPS) and a C-terminal SH2 domain. The SH2 domains of Grb7, Grb10 and Grb14 preferentially bind to a different RTK. Grb7 binds strongly to the erbB2 receptor, unlike Grb10 and Grb14 which bind weakly to it. Grb14 binds to Fibroblast Growth Factor Receptor (FGFR). Grb10 has been shown to interact with many different proteins, including the insulin and IGF1 receptors, platelet-derived growth factor (PDGF) receptor-beta, Ret, Kit, Raf1 and MEK1, and Nedd4. Grb7 family proteins are phosphorylated on serine/threonine as well as tyrosine residues. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198197 [Multi-domain]  Cd Length: 108  Bit Score: 38.94  E-value: 2.34e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....*
gi 1907068278 1006 SKYWYKPEISREQAIALLKDQ--EPGAFIIRDSHSFRGAYGLAMK 1048
Cdd:cd09944      4 SQPWFHGGISRDEAARLIRQQglVDGVFLVRESQSNPGAFVLSLK 48
SH2_csk_like cd09937
Src homology 2 (SH2) domain found in Carboxyl-Terminal Src Kinase (Csk); Both the C-terminal ...
 1009-1047 2.47e-03

Src homology 2 (SH2) domain found in Carboxyl-Terminal Src Kinase (Csk); Both the C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK) are members of the CSK-family of protein tyrosine kinases. These proteins suppress activity of Src-family kinases (SFK) by selectively phosphorylating the conserved C-terminal tail regulatory tyrosine by a similar mechanism. CHK is also capable of inhibiting SFKs by a non-catalytic mechanism that involves binding of CHK to SFKs to form stable protein complexes. The unphosphorylated form of SFKs is inhibited by CSK and CHK by a two-step mechanism. The first step involves the formation of a complex of SFKs with CSK/CHK with the SFKs in the complex are inactive. The second step, involves the phosphorylation of the C-terminal tail tyrosine of SFKs, which then dissociates and adopt an inactive conformation. The structural basis of how the phosphorylated SFKs dissociate from CSK/CHK to adopt the inactive conformation is not known. The inactive conformation of SFKs is stabilized by two intramolecular inhibitory interactions: (a) the pYT:SH2 interaction in which the phosphorylated C-terminal tail tyrosine (YT) binds to the SH2 domain, and (b) the linker:SH3 interaction of which the SH2-kinase domain linker binds to the SH3 domain. SFKs are activated by multiple mechanisms including binding of the ligands to the SH2 and SH3 domains to displace the two inhibitory intramolecular interactions, autophosphorylation, and dephosphorylation of YT. By selective phosphorylation and the non-catalytic inhibitory mechanism CSK and CHK are able to inhibit the active forms of SFKs. CSK and CHK are regulated by phosphorylation and inter-domain interactions. They both contain SH3, SH2, and kinase domains separated by the SH3-SH2 connector and SH2 kinase linker, intervening segments separating the three domains. They lack a conserved tyrosine phosphorylation site in the kinase domain and the C-terminal tail regulatory tyrosine phosphorylation site. The CSK SH2 domain is crucial for stabilizing the kinase domain in the active conformation. A disulfide bond here regulates CSK kinase activity. The subcellular localization and activity of CSK are regulated by its SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198190  Cd Length: 98  Bit Score: 38.43  E-value: 2.47e-03
                           10        20        30
                   ....*....|....*....|....*....|....*....
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAM 1047
Cdd:cd09937      5 WFHGKISREEAERLLQPPEDGLFLVRESTNYPGDYTLCV 43
SH2_cSH2_p85_like cd09930
C-terminal Src homology 2 (cSH2) domain found in p85; Phosphoinositide 3-kinases (PI3Ks) are ...
 1009-1104 2.67e-03

C-terminal Src homology 2 (cSH2) domain found in p85; Phosphoinositide 3-kinases (PI3Ks) are essential for cell growth, migration, and survival. p110, the catalytic subunit, is composed of an adaptor-binding domain, a Ras-binding domain, a C2 domain, a helical domain, and a kinase domain. The regulatory unit is called p85 and is composed of an SH3 domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain, a inter SH2 (iSH2) domain, and C-terminal (cSH2) domain. There are 2 inhibitory interactions between p110alpha and p85 of P13K: 1) p85 nSH2 domain with the C2, helical, and kinase domains of p110alpha and 2) p85 iSH2 domain with C2 domain of p110alpha. There are 3 inhibitory interactions between p110beta and p85 of P13K: 1) p85 nSH2 domain with the C2, helical, and kinase domains of p110beta, 2) p85 iSH2 domain with C2 domain of p110alpha, and 3) p85 cSH2 domain with the kinase domain of p110alpha. It is interesting to note that p110beta is oncogenic as a wild type protein while p110alpha lacks this ability. One explanation is the idea that the regulation of p110beta by p85 is unique because of the addition of inhibitory contacts from the cSH2 domain and the loss of contacts in the iSH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198184  Cd Length: 104  Bit Score: 38.55  E-value: 2.67e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDShSFRGAYGLAMKVSSppptitqqgkkgdmtheLVRHFLIETGPRGVKLKgcp 1088
Cdd:cd09930      8 WLVGDINRTQAEELLRGKPDGTFLIRES-STQGCYACSVVCNG-----------------EVKHCVIYKTETGYGFA--- 66

                           90       100
                   ....*....|....*....|
gi 1907068278 1089 nEPN--FGSLSALV--YQHS 1104
Cdd:cd09930     67 -EPYnlYESLKELVlhYAHN 85
SH2_SOCS_family cd09923
Src homology 2 (SH2) domain found in suppressor of cytokine signaling (SOCS) family; SH2 ...
 1009-1036 2.76e-03

Src homology 2 (SH2) domain found in suppressor of cytokine signaling (SOCS) family; SH2 domain found in SOCS proteins. SOCS was first recognized as a group of cytokine-inducible SH2 (CIS) domain proteins comprising eight family members in human (CIS and SOCS1-SOCS7). In addition to the SH2 domain, SOCS proteins have a variable N-terminal domain and a conserved SOCS box in the C-terminal domain. SOCS proteins bind to a substrate via their SH2 domain. The prototypical members, CIS and SOCS1-SOCS3, have been shown to regulate growth hormone signaling in vitro and in a classic negative feedback response compete for binding at phosphotyrosine sites in JAK kinase and receptor pathways to displace effector proteins and target bound receptors for proteasomal degradation. Loss of SOCS activity results in excessive cytokine signaling associated with a variety of hematopoietic, autoimmune, and inflammatory diseases and certain cancers. Members (SOCS4-SOCS7) were identified by their conserved SOCS box, an adapter motif of 3 helices that associates substrate binding domains, such as the SOCS SH2 domain, ankryin, and WD40 with ubiquitin ligase components. These show limited cytokine induction. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198178  Cd Length: 81  Bit Score: 37.95  E-value: 2.76e-03
                           10        20
                   ....*....|....*....|....*...
gi 1907068278 1009 WYKPEISREQAIALLKDQEPGAFIIRDS 1036
Cdd:cd09923      2 WYWGGITRYEAEELLAGKPEGTFLVRDS 29
Chi1 COG3469
Chitinase [Carbohydrate transport and metabolism];
731-936 4.12e-03

Chitinase [Carbohydrate transport and metabolism];


Pssm-ID: 442692 [Multi-domain]  Cd Length: 534  Bit Score: 41.28  E-value: 4.12e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  731 TVGTNTPPSPGFGRRAVNPTMAAPGSPSLSHRQVMGPSGPGFHGNVVSGHPASAATTPGSPSLGRHPVGSHQVPGLHSSV 810
Cdd:COG3469      4 VSTAASPTAGGASATAVTLLGAAATAASVTLTAATATTVVSTTGSVVVAASGSAGSGTGTTAASSTAATSSTTSTTATAT 83

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  811 VTTPGSPSLGRHPGAHQGNLASSLHSNAVISPGSPSLGRHLGGSGSVVPGSPSLDRHAAYGGYSTPEDRRPTL------S 884
Cdd:COG3469     84 AAAAAATSTSATLVATSTASGANTGTSTVTTTSTGAGSVTSTTSSTAGSTTTSGASATSSAGSTTTTTTVSGTetatggT 163

                          170       180       190       200       210
                   ....*....|....*....|....*....|....*....|....*....|..
gi 1907068278  885 RQSSASGYQAPSTPSFPVSPAYYPGLSSPATSPSPDSAAFRQGSPTPALPEK 936
Cdd:COG3469    164 TTTSTTTTTTSASTTPSATTTATATTASGATTPSATTTATTTGPPTPGLPKH 215
SH2_SLAP cd10344
Src homology 2 domain found in Src-like adaptor proteins; SLAP belongs to the subfamily of ...
 1009-1052 5.40e-03

Src homology 2 domain found in Src-like adaptor proteins; SLAP belongs to the subfamily of adapter proteins that negatively regulate cellular signaling initiated by tyrosine kinases. It has a myristylated N-terminus, SH3 and SH2 domains with high homology to Src family tyrosine kinases, and a unique C-terminal tail, which is important for c-Cbl binding. SLAP negatively regulates platelet-derived growth factor (PDGF)-induced mitogenesis in fibroblasts and regulates F-actin assembly for dorsal ruffles formation. c-Cbl mediated SLAP inhibition towards actin remodeling. Moreover, SLAP enhanced PDGF-induced c-Cbl phosphorylation by SFK. In contrast, SLAP mitogenic inhibition was not mediated by c-Cbl, but it rather involved a competitive mechanism with SFK for PDGF-receptor (PDGFR) association and mitogenic signaling. Accordingly, phosphorylation of the Src mitogenic substrates Stat3 and Shc were reduced by SLAP. Thus, we concluded that SLAP regulates PDGFR signaling by two independent mechanisms: a competitive mechanism for PDGF-induced Src mitogenic signaling and a non-competitive mechanism for dorsal ruffles formation mediated by c-Cbl. SLAP is a hematopoietic adaptor containing Src homology (SH)3 and SH2 motifs and a unique carboxy terminus. Unlike c-Src, SLAP lacks a tyrosine kinase domain. Unlike c-Src, SLAP does not impact resorptive function of mature osteoclasts but induces their early apoptosis. SLAP negatively regulates differentiation of osteoclasts and proliferation of their precursors. Conversely, SLAP decreases osteoclast death by inhibiting activation of caspase 3. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198207  Cd Length: 104  Bit Score: 37.86  E-value: 5.40e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....*.
gi 1907068278 1009 WYKPEISREQAIALLK--DQEPGAFIIRDSHSFRGAYGLAMKVSSP 1052
Cdd:cd10344     12 WLFEGLSREKAEELLMlpGNQVGSFLIRESETRRGCYSLSVRHRGS 57
COG5099 COG5099
RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal ...
 660-1026 5.52e-03

RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis];


Pssm-ID: 227430 [Multi-domain]  Cd Length: 777  Bit Score: 40.89  E-value: 5.52e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  660 DSSIRSGSLGQPSPAALSYQSSSP--VPVGGSSYNSPDYSLQPFSSSPESQGQPQYSAASVHmvpGSPQARHRTVGTNTP 737
Cdd:COG5099     73 SSSSRRKPSGSWSVAISSSTSGSQslLMELPSSSFNPSTSSRNKSNSALSSTQQGNANSSVT---LSSSTASSMFNSNKL 149

                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  738 PSPGFGrraVNPTMAAPGSPSLSHrqvMGPSgPGFHGNVVSghPASAATTPGSPSLGRHPVGSHQVPGLhSSVVTTPGSP 817
Cdd:COG5099    150 PLPNPN---HSNSATTNQSGSSFI---NTPA-SSSSQPLTN--LVVSSIKRFPYLTSLSPFFNYLIDPS-SDSATASADT 219

                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  818 SLgrhpgahQGNLASSLHSNAVISPGSPSLGRH---LGGSGSVVPGSPSLDRHAAYGGYSTPEDRRPT-------LSRQS 887
Cdd:COG5099    220 SP-------SFNPPPNLSPNNLFSTSDLSPLPDtqsVENNIILNSSSSINELTSIYGSVPSIRNLRGLnsalvsfLNVSS 292

                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1907068278  888 SASGYQAPSTPsfPVSPAYYPGLSSPATSPSPDSA-AFRQGSPTPA-LPEKRRMSVGDRagSLPNYATIN-GKVSSSPVA 964
Cdd:COG5099    293 SSLAFSALNGK--EVSPTGSPSTRSFARVLPKSSPnNLLTEILTTGvNPPQSLPSLLNP--VFLSTSTGFsLTNLSGYLN 368

                          330       340       350       360       370       380
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1907068278  965 NGMASGSSTVSFSHTLPDFSKYSMPDNSPETRAKVKFVQDTskywYKPEISREQAIALLKDQ 1026
Cdd:COG5099    369 PNKNLKKNTLSSLSNLGYSSNVPSPSSSESTRNILGNISPN----FKTSSNLTNLNSLLKEK 426
SH2_Cterm_RasGAP cd10354
C-terminal Src homology 2 (SH2) domain found in Ras GTPase-activating protein 1 (GAP); RasGAP ...
 1009-1081 5.62e-03

C-terminal Src homology 2 (SH2) domain found in Ras GTPase-activating protein 1 (GAP); RasGAP is part of the GAP1 family of GTPase-activating proteins. The protein is located in the cytoplasm and stimulates the GTPase activity of normal RAS p21, but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in RAS inactivation, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Alternative splicing results in two isoforms. The shorter isoform which lacks the N-terminal hydrophobic region, has the same activity, and is expressed in placental tissues. In general longer isoform contains 2 SH2 domains, a SH3 domain, a pleckstrin homology (PH) domain, and a calcium-dependent phospholipid-binding C2 domain. The C-terminus contains the catalytic domain of RasGap which catalyzes the activation of Ras by hydrolyzing GTP-bound active Ras into an inactive GDP-bound form of Ras. This model contains the C-terminal SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198217  Cd Length: 77  Bit Score: 37.02  E-value: 5.62e-03
                           10        20        30        40        50        60        70
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1907068278 1009 WYKPEISREQAIALL-KDQEPGAFIIRDSHSFRGAYGLAMKVSsppptitqqgkkgdmthELVRHFLIETGPRG 1081
Cdd:cd10354      2 WFHGKISREEAYNMLvKVGGPGSFLVRESDNTPGDYSLSFRVN-----------------EGIKHFKIIPTGNN 58
SH2_a2chimerin_b2chimerin cd10352
Src homology 2 (SH2) domain found in alpha2-chimerin and beta2-chimerin proteins; Chimerins ...
 1014-1048 7.12e-03

Src homology 2 (SH2) domain found in alpha2-chimerin and beta2-chimerin proteins; Chimerins are a family of phorbol ester- and diacylglycerol-responsive GTPase-activating proteins. Alpha1-chimerin (formerly known as n-chimerin) and alpha2-chimerin are alternatively spliced products of a single gene, as are beta1- and beta2-chimerin. alpha1- and beta1-chimerin have a relatively short N-terminal region that does not encode any recognizable domains, whereas alpha2- and beta2-chimerin both include a functional SH2 domain that can bind to phosphotyrosine motifs within receptors. All of the isoforms contain a GAP domain with specificity in vitro for Rac1 and a diacylglycerol (DAG)-binding C1 domain which allows them to translocate to membranes in response to DAG signaling and anchors them in close proximity to activated Rac. Other C1 domain-containing diacylglycerol receptors including: PKC, Munc-13 proteins, phorbol ester binding scaffolding proteins involved in Ca2+-stimulated exocytosis, and RasGRPs, diacylglycerol-activated guanine-nucleotide exchange factors (GEFs) for Ras and Rap1. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.


Pssm-ID: 198215  Cd Length: 91  Bit Score: 36.96  E-value: 7.12e-03
                           10        20        30
                   ....*....|....*....|....*....|....*
gi 1907068278 1014 ISREQAIALLKDQEPGAFIIRDSHSFRGAYGLAMK 1048
Cdd:cd10352     13 ISREEAEQLLSGASDGSYLIRESSRDDGYYTLSLR 47
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH